The interplay of reactive oxygen species, hypoxia, inflammation, and sirtuins in cancer initiation and progression
M Tafani, L Sansone, F Limana… - Oxidative medicine …, 2016 - Wiley Online Library
The presence of ROS is a constant feature in living cells metabolizing O2. ROS
concentration and compartmentation determine their physiological or pathological effects …
concentration and compartmentation determine their physiological or pathological effects …
Chemoprevention of cancer
AS Tsao, ES Kim, WK Hong - CA: a cancer journal for clinicians, 2004 - Wiley Online Library
Cancer chemoprevention is defined as the use of natural, synthetic, or biologic chemical
agents to reverse, suppress, or prevent carcinogenic progression to invasive cancer. The …
agents to reverse, suppress, or prevent carcinogenic progression to invasive cancer. The …
Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity
CM Remsberg, JA Yáñez, Y Ohgami… - … Journal Devoted to …, 2008 - Wiley Online Library
The present study evaluated the preclinical pharmacokinetics and pharmacodynamics of
trans‐pterostilbene, a constituent of some plants. Right jugular vein cannulated male …
trans‐pterostilbene, a constituent of some plants. Right jugular vein cannulated male …
[Retracted] The Crucial Role of CXCL8 and Its Receptors in Colorectal Liver Metastasis
Y Bie, W Ge, Z Yang, X Cheng, Z Zhao, S Li… - Disease …, 2019 - Wiley Online Library
CXCL8 (also known as IL‐8) can produce different biological effects by binding to its
receptors: CXCR1, CXCR2, and the Duffy antigen receptor for chemokines (DARC). CXCL8 …
receptors: CXCR1, CXCR2, and the Duffy antigen receptor for chemokines (DARC). CXCL8 …
[HTML][HTML] Rationale and means to target pro-inflammatory interleukin-8 (CXCL8) signaling in cancer
LM Campbell, PJ Maxwell, DJJ Waugh - Pharmaceuticals, 2013 - mdpi.com
It is well established that chronic inflammation underpins the development of a number of
human cancers, with pro-inflammatory signaling within the tumor microenvironment …
human cancers, with pro-inflammatory signaling within the tumor microenvironment …
5 Selective inhibitors of cyclooxygenase-2 (COT-2)
JJ Talley - Progress in medicinal chemistry, 1999 - Elsevier
Publisher Summary This chapter focuses on selective inhibitors of cyclooxygenase-2 (COX-
2). Two distinct COX enzymes were recently identified (i) a constitutive form (COX-1) present …
2). Two distinct COX enzymes were recently identified (i) a constitutive form (COX-1) present …
Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection
J Rüschoff, S Wallinger, W Dietmaier… - Proceedings of the …, 1998 - National Acad Sciences
Nonsteroidal anti-inflammatory drugs (NSAIDs) are well-known cancer preventives, which
have been largely attributed to their antiproliferative and apoptosis-inducing activities. In this …
have been largely attributed to their antiproliferative and apoptosis-inducing activities. In this …
Adverse effects of nonsteroidal anti-inflammatory drugs on the gastrointestinal system
E Fosslien - Annals of Clinical & Laboratory Science, 1998 - Assoc Clin Scientists
Two enzymes, cyclo-oxygenase (COX) and 5-lipoxygenase, act upon arachidonic acids to
produce prostaglandins and leukotrienes. Inhibition of COX-2 by non-steroidal anti …
produce prostaglandins and leukotrienes. Inhibition of COX-2 by non-steroidal anti …
[HTML][HTML] Modulators of HIF1α and NFkB in cancer treatment: is it a rational approach for controlling malignant progression?
HIF1α and NFkB are two transcription factors very frequently activated in tumors and
involved in tumor growth, progression, and resistance to chemotherapy. In fact, HIF1α and …
involved in tumor growth, progression, and resistance to chemotherapy. In fact, HIF1α and …
Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma
AW Bak, W McKnight, P Li, P Del Soldato, A Calignano… - Life Sciences, 1998 - Elsevier
Aspirin decreases the risk of colorectal cancer, reportedly through suppression of
cyclooxygenase (COX) activity. Using a rat model of colonic adenocarcinoma, we compared …
cyclooxygenase (COX) activity. Using a rat model of colonic adenocarcinoma, we compared …